Brazil shipped US$ 5.0M in enzymes to Paraguay in January–May 2026, a 28.3% gain in dollar value and a 16.3% rise in volume versus a year earlier.
Brazil's enzyme shipments to Paraguay totaled US$ 5.0M FOB from January through May 2026 — up 28.3% in dollar value versus the same five months of 2025, when receipts stood at US$ 3.9M. In weight, volumes reached 568,700 kg, compared with 488,800 kg a year prior: a gain of 16.3%.
When a trade corridor grows 16% by weight and 28% by dollars simultaneously, something has changed in either product mix or pricing power. The most likely candidates: a shift toward higher-value enzyme formulations (specialty industrial or food-grade versus commodity animal-feed enzymes), an FX tailwind from a weaker real that let exporters lift dollar prices without losing competitiveness, or both working together.
The broader context matters. The BACEN PTAX rate trended toward a weaker real in early 2026, making dollar-denominated exports more profitable for Brazilian suppliers. That kind of margin buffer typically encourages exporters to nudge prices upward rather than pass the full gain in volume. Average price per kilogram shipped rose roughly 10% in the comparison — a meaningful margin capture in an industry where formulation complexity is the key differentiator.
Current volumes are also running 17.4% above the historical seasonal median for the same January–May window across prior years. That excess over the norm points to something beyond year-on-year noise:
Brazil is a significant intrablock exporter of industrial enzymes, particularly to Mercosur partners. Production is concentrated in the interior of São Paulo state and parts of Minas Gerais, supplying sectors ranging from animal feed and food processing to pulp and paper. Mercosur's common external tariff gives Brazilian suppliers a structural price advantage over non-bloc competitors in this segment, one that becomes more pronounced when the real weakens.
The January–May 2026 volume beats not just the prior-year window but also the historical seasonal average — a sign that demand is running ahead of the underlying trend, not merely recovering from a soft 2025. MDIC ComexStat data confirms the acceleration. Paraguay may be a small market in absolute terms, but for specialized enzyme producers in Brazil's interior, it represents a steady and growing revenue line that compounds quietly year after year.
With value growing close to 12 percentage points faster than volume, the average price per kilogram exported rose roughly 10% on a year-over-year basis. This type of movement typically occurs when the exporter can pass through production costs, the product mix shifts toward higher-value formulations, or a favorable exchange rate widens margins without needing to cut prices in local-currency terms. All three factors may be operating at once — which is why the divergence between volume and value growth deserves more attention than the headline numbers alone suggest.
Puerto Rico vaults to #1 in Brazilian pharmaceutical exports in 2026
Exports
Brazil's artificial filament yarn to South Africa up 10-fold
Exports
Brazil's refined oil exports to Poland jump 7x
Exports
China vaults from nowhere to #1 in Brazil's oilseed exports
Agribusiness
China vaults from 14th to top buyer of Brazilian biologics in YTD run
China